LLY

Q: What is the price of Eli Lilly (LLY) today?

The price of Eli Lilly (LLY) today is $ 1,070.16, with return of 43.04% compared to the last year. The price of Eli Lilly (LLY) started the year trading around $ 778.07 and today it is at $ 1,070.16. Follow the real-time price chart, the historical price of Eli Lilly (LLY) and international markets.

Q: When does Eli Lilly (LLY) pay dividends?

Eli Lilly (LLY) distributed dividends in the last year,in the months of March, June and September totaling $ 4.50. The Dividend Yield for the last 12 months is 0.55%.

Q: Is Eli Lilly (LLY) worth it?

Currently, Eli Lilly (LLY) is priced at $ 1,070.16, with a P/E of 51.55%, representando um desvio de 6,223% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 43.04 in its price and distributed $ 4.50 in dividends, resulting in a Dividend Yield of 0.55%. The total shareholder return was 43.04%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Eli Lilly (LLY) stock?

Investing in stocks of Eli Lilly (LLY) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Eli Lilly (LLY) yield today?

The yield of Eli Lilly (LLY) was 29.84% in the last month, 43.04% in the last year and 668.63% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 5.80 in dividends, a Dividend Yield of 0.55%.If you wanted to buy 100 stocks of Eli Lilly (LLY) today, the total investment would be $ 107,016.00, based on the current price of $ 1,070.16.If past performance were to repeat, the return on your investment would be:In 1 year: $ 153,075.69In 5 years: $ 822,557.08In 10 years: $ 1,668,197.51It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Eli Lilly and Compay

Price

$ 1,070.16

return (12m)

43.04%

p/e

51.55

p/bv

39.80

DIVIDEND YIELD

0.55%

price LLY

BVMF

LLY

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, you would now have

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of LLY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

29.84%

3 months

46.29%

1 year

43.04%

2 years

83.80%

5 years

668.63%

10 years

1,458.83%

Fundamentals LLY

review the fundamentals of Eli Lilly shares

P/E

51.55

Sector: -2.16 Industry: -4.35

P/SALES RATIO (PSR)

15.97

Sector: 1.99 Industry: 2.82

P/BV

39.80

Sector: 2.12 Industry: 1.99

DIVIDEND YIELD (DY)

0.55%

Sector: - Industry: -

ROA

16.02%

Sector: -26.99% Industry: -53.23%

ROE

77.20%

Sector: -30.03% Industry: -43.96%

ROIC

36.41%

Sector: -414.93% Industry: -472.50%

NET MARGIN

30.99%

Sector: -27.97% Industry: -32.87%

GROSS MARGIN

83.03%

Sector: 44.10% Industry: 45.08%

OPERATING MARGIN

45.16%

Sector: -24.33% Industry: -29.79%

P/EBITDA

37.52

Sector: -0.32 Industry: -3.32

P/EBIT

40.56

Sector: -2.46 Industry: -4.39

P/ASSET

8.26

Sector: 1.19 Industry: 1.35

BVPS

26.59

Sector: 3.38 Industry: 1.66

EPS

20.53

Sector: -0.89 Industry: -1.28

EQUITY RATIO

0.21

Sector: 0.43 Industry: 0.46

CAGR REVENUE 5 YEARS

19.35%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

24.35%

Sector: - Industry: -

FAIR VALUE OF Eli Lilly ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 1,070.16

Fair Value

$ 0.00

Upside Return potential.

-89.64%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LLY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
ISRG	72.99	11.76	16.12%	0.00%	$ 200.49 B	28.58%
TMO	33.80	4.34	12.84%	0.29%	$ 222.07 B	15.02%
SNY	10.79	1.50	13.90%	4.46%	$ 121.64 B	14.83%
MDT	27.23	0.00	0.00%	2.79%	$ 129.74 B	13.71%
NVS	17.04	5.48	32.16%	3.04%	$ 245.20 B	25.53%
ABT	15.34	4.18	27.26%	1.89%	$ 214.39 B	31.88%
CVS	211.13	1.35	0.64%	3.41%	$ 99.02 B	0.12%
GSK	12.93	4.43	34.29%	3.52%	$ 94.37 B	17.23%
BSX	51.42	0.00	0.00%	0.00%	$ 143.58 B	14.43%
TMDX	48.51	12.53	25.84%	0.00%	$ 4.45 B	16.20%
HCA	18.03	-52.99	-293.84%	0.57%	$ 114.40 B	8.53%
IDXX	56.52	37.20	65.81%	0.00%	$ 58.07 B	24.65%
INMD	5.92	1.36	22.89%	0.00%	$ 885.78 M	41.04%
DHR	46.15	3.17	6.86%	0.54%	$ 161.67 B	14.43%
FMS	16.76	0.84	5.00%	3.36%	$ 13.67 B	3.73%
RMD	25.40	5.97	23.49%	0.88%	$ 36.52 B	27.35%
PHG	115.12	2.09	1.81%	3.25%	$ 25.92 B	1.14%
HUM	21.11	1.47	6.95%	1.56%	$ 27.25 B	1.02%
SYK	47.80	6.46	13.51%	0.91%	$ 140.68 B	12.07%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

LLY Historical Dividends

current DY: 0.55%

5-year average DY: 1.14%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	11/14/2025	12/10/2025	1,50000000
Dividend	08/15/2025	09/10/2025	1,50000000
Dividend	05/16/2025	06/10/2025	1,50000000
Dividend	02/14/2025	03/10/2025	1,50000000
Dividend	11/15/2024	12/10/2024	1,30000000
Dividend	08/15/2024	09/10/2024	1,30000000
Dividend	05/16/2024	06/10/2024	1,30000000
Dividend	02/15/2024	03/08/2024	1,30000000
Dividend	11/15/2023	12/08/2023	1,13000000
Dividend	08/15/2023	09/08/2023	1,13000000
Dividend	05/15/2023	06/09/2023	1,13000000
Dividend	02/15/2023	03/10/2023	1,13000000
Dividend	11/15/2022	12/09/2022	0,98000000
Dividend	08/15/2022	09/09/2022	0,98000000
Dividend	05/16/2022	06/10/2022	0,98000000
Dividend	02/15/2022	03/10/2022	0,98000000
Dividend	11/15/2021	12/10/2021	0,85000000
Dividend	08/13/2021	09/10/2021	0,85000000
Dividend	05/14/2021	06/10/2021	0,85000000
Dividend	02/12/2021	03/10/2021	0,85000000
Dividend	11/13/2020	12/10/2020	0,74000000
Dividend	08/14/2020	09/10/2020	0,74000000
Dividend	05/15/2020	06/10/2020	0,74000000
Dividend	02/14/2020	03/10/2020	0,74000000
Dividend	11/15/2019	12/10/2019	0,64500000
Dividend	08/15/2019	09/10/2019	0,64500000
Dividend	05/17/2019	06/10/2019	0,64500000
Dividend	02/15/2019	03/08/2019	0,64500000
Dividend	11/15/2018	12/10/2018	0,56300000
Dividend	08/15/2018	09/10/2018	0,56300000
Dividend	05/17/2018	06/08/2018	0,56300000
Dividend	02/15/2018	03/09/2018	0,56300000
Dividend	11/15/2017	12/08/2017	0,52000000
Dividend	08/15/2017	09/08/2017	0,52000000
Dividend	05/15/2017	06/09/2017	0,52000000
Dividend	02/15/2017	03/10/2017	0,52000000
Dividend	11/15/2016	12/09/2016	0,51000000
Dividend	08/15/2016	09/09/2016	0,51000000
Dividend	05/13/2016	06/10/2016	0,51000000
Dividend	02/12/2016	03/10/2016	0,51000000
Dividend	11/13/2015	12/10/2015	0,50000000
Dividend	08/14/2015	09/10/2015	0,50000000
Dividend	05/18/2015	06/10/2015	0,50000000
Dividend	02/13/2015	03/10/2015	0,50000000
Dividend	11/14/2014	12/10/2014	0,49000000
Dividend	08/15/2014	09/10/2014	0,49000000
Dividend	05/15/2014	06/10/2014	0,49000000
Dividend	02/14/2014	03/10/2014	0,49000000
Dividend	11/15/2013	12/10/2013	0,49000000
Dividend	08/15/2013	09/10/2013	0,49000000
Dividend	05/16/2013	06/10/2013	0,49000000
Dividend	02/15/2013	03/08/2013	0,49000000
Dividend	11/15/2012	12/10/2012	0,49000000
Dividend	08/15/2012	09/10/2012	0,49000000
Dividend	05/15/2012	06/08/2012	0,49000000
Dividend	02/15/2012	03/09/2012	0,49000000
Dividend	11/15/2011	12/09/2011	0,49000000
Dividend	08/15/2011	09/09/2011	0,49000000
Dividend	05/13/2011	06/10/2011	0,49000000
Dividend	02/15/2011	03/10/2011	0,49000000
Dividend	11/15/2010	12/10/2010	0,49000000
Dividend	08/13/2010	09/10/2010	0,49000000
Dividend	05/14/2010	06/10/2010	0,49000000
Dividend	02/12/2010	03/10/2010	0,49000000
Dividend	11/13/2009	12/10/2009	0,49000000
Dividend	08/15/2009	09/10/2009	0,49000000
Dividend	05/15/2009	06/10/2009	0,49000000
Dividend	02/13/2009	03/10/2009	0,49000000
Dividend	11/14/2008	12/10/2008	0,47000000
Dividend	08/15/2008	09/10/2008	0,47000000
Dividend	05/15/2008	06/10/2008	0,47000000
Dividend	02/15/2008	03/10/2008	0,47000000
Dividend	11/15/2007	12/10/2007	0,42500000
Dividend	08/15/2007	09/10/2007	0,42500000
Dividend	05/15/2007	06/08/2007	0,42500000
Dividend	02/15/2007	03/09/2007	0,42500000
Dividend	11/15/2006	12/08/2006	0,40000000
Dividend	08/15/2006	09/08/2006	0,40000000
Dividend	05/15/2006	06/09/2006	0,40000000
Dividend	02/15/2006	03/10/2006	0,40000000
Dividend	11/15/2005	12/09/2005	0,38000000
Dividend	08/15/2005	09/09/2005	0,38000000
Dividend	05/13/2005	06/10/2005	0,38000000
Dividend	02/15/2005	03/10/2005	0,38000000
Dividend	11/15/2004	12/10/2004	0,35500000
Dividend	08/13/2004	09/10/2004	0,35500000
Dividend	05/14/2004	06/10/2004	0,35500000
Dividend	02/13/2004	03/10/2004	0,35500000
Dividend	11/14/2003	12/10/2003	0,33500000
Dividend	08/15/2003	09/10/2003	0,33500000
Dividend	05/15/2003	06/10/2003	0,33500000
Dividend	02/14/2003	03/10/2003	0,33500000
Dividend	11/15/2002	12/10/2002	0,31000000
Dividend	08/15/2002	09/10/2002	0,31000000
Dividend	05/15/2002	06/10/2002	0,31000000
Dividend	02/15/2002	03/08/2002	0,31000000
Dividend	11/15/2001	12/10/2001	0,28000000
Dividend	08/15/2001	09/10/2001	0,28000000
Dividend	05/15/2001	06/11/2001	0,28000000
Dividend	02/15/2001	03/09/2001	0,28000000
Dividend	11/15/2000	12/11/2000	0,26000000
Dividend	08/15/2000	09/11/2000	0,26000000
Dividend	05/15/2000	06/09/2000	0,26000000
Dividend	02/15/2000	03/10/2000	0,26000000
Dividend	11/15/1999	12/10/1999	0,23000000
Dividend	08/13/1999	09/10/1999	0,23000000
Dividend	05/14/1999	06/10/1999	0,23000000
Dividend	02/12/1999	03/10/1999	0,23000000
Dividend	11/13/1998	12/10/1998	0,20000000
Dividend	08/14/1998	09/10/1998	0,20000000
Dividend	05/15/1998	06/10/1998	0,20000000
Dividend	02/13/1998	03/10/1998	0,20000000
Dividend	11/14/1997	12/10/1997	0,20000000
Dividend	08/15/1997	09/10/1997	0,18000000
Dividend	05/15/1997	06/10/1997	0,18000000
Dividend	02/14/1997	03/10/1997	0,18000000
Dividend	11/15/1996	12/10/1996	0,17100000
Dividend	08/15/1996	09/10/1996	0,17100000
Dividend	05/15/1996	06/10/1996	0,17100000
Dividend	02/15/1996	03/11/1996	0,17100000
Dividend	11/15/1995	12/11/1995	0,17125000
Dividend	08/15/1995	09/11/1995	0,16125000
Dividend	05/15/1995	06/12/1995	0,16125000
Dividend	02/15/1995	03/10/1995	0,16125000
Dividend	11/15/1994	12/12/1994	0,15625000
Dividend	08/15/1994	09/12/1994	0,15625000
Dividend	05/13/1994	06/10/1994	0,15625000
Dividend	02/15/1994	03/10/1994	0,15625000
Dividend	11/15/1993	12/10/1993	0,15125000
Dividend	08/13/1993	09/10/1993	0,15125000
Dividend	05/14/1993	06/10/1993	0,15125000
Dividend	02/16/1993	03/10/1993	0,15125000
Dividend	11/13/1992	12/10/1992	0,13750000
Dividend	08/14/1992	09/10/1992	0,13750000
Dividend	05/15/1992	06/10/1992	0,13750000
Dividend	02/14/1992	03/10/1992	0,13750000
Dividend	11/15/1991	12/10/1991	0,12500000
Dividend	08/15/1991	09/10/1991	0,12500000
Dividend	05/15/1991	06/08/1991	0,12500000
Dividend	02/13/1991	03/09/1991	0,12500000
Dividend	11/15/1990	12/08/1990	0,10250000
Dividend	08/15/1990	09/08/1990	0,10250000
Dividend	05/15/1990	06/09/1990	0,10250000
Dividend	02/15/1990	03/10/1990	0,10250000

ABOUT THE COMPANY Eli Lilly

Eli Lilly and Compay

Average user rating I10

4.0 (298 people)

United States

124 years

Founded: 1901

1970

Time since IPO - 55 years

35.000

Employees

Eli Lilly and Company operates in the healthcare sector, specifically within the pharmaceutical industry.

The company was founded in 1876 in the United States by chemist and pharmacist Eli Lilly.

Since its inception, the company’s mission has been to develop innovative medicines that improve health outcomes and the quality of life for patients with chronic and complex diseases.

Lilly’s diverse portfolio includes treatments for diabetes, oncology, neuroscience, immunology, and rare diseases. Among its most well-known products are:

Insulin therapies and diabetes treatments such as insulin lispro and Trulicity
Oncology drugs for various types of cancer, including lung and breast cancer
Neurological treatments, including therapies for Alzheimer’s disease and psychiatric disorders
Immunological therapies, including medications for rheumatoid arthritis and psoriasis

With a presence in over 120 countries, Eli Lilly has strong operations in the United States, Europe, Latin America, and Asia. Its global infrastructure includes headquarters in Indianapolis, Indiana, along with research centers, manufacturing facilities, and strategic offices around the world.

The company operates a research-intensive business model, dedicating significant investments to R&D, aiming to discover new molecules and enhance existing treatments. Strategic partnerships with other pharmaceutical companies and academic institutions further accelerate drug development.

Eli Lilly employs approximately 35,000 people and operates through a global network of innovation centers, production sites, and distribution hubs. Its commitment to science and innovation ensures the ongoing development of breakthrough medicines and healthcare solutions.

The company's shares are traded on the New York Stock Exchange (NYSE) under the ticker LLY.

History and Founding of Eli Lilly and Company

Eli Lilly and Company was founded in 1876 in the United States by Eli Lilly, a chemist and pharmaceutical pioneer. His vision was to create a company that would produce scientifically formulated, high-quality medicines at a time when many treatments lacked efficacy and standardization.

In its early years, the company differentiated itself by introducing standardized drug manufacturing practices, setting a new benchmark in pharmaceutical production. Despite challenges in distribution and market penetration, Eli Lilly's dedication to innovation enabled rapid growth.

By the early 20th century, the company had become one of the largest pharmaceutical producers in the U.S. In 1923, Eli Lilly made history by introducing the first commercial insulin for diabetes treatment, dramatically improving the lives of patients worldwide.

During the 1950s, the company expanded into treatments for psychiatric and cardiovascular disorders, and by the 1980s, it was pioneering biotechnology-based drugs, reinforcing its position as a leader in the pharmaceutical industry.

Eli Lilly went public with its Initial Public Offering (IPO) on the NYSE, leveraging the capital to scale its operations and R&D initiatives.

In the 2000s, the company broadened its scope into oncology, immunology, and neuroscience, launching new drugs and expanding into emerging markets.

Key milestones from 2020 to 2024 include:

2020: Expanded investments in biotechnology and digital healthcare innovation
2021: Launched new therapies for diabetes and autoimmune diseases
2022: Acquired startups focused on gene therapy development
2023–2024: Advanced research in Alzheimer’s disease and cancer treatments

Today, Eli Lilly and Company is recognized as one of the world’s leading pharmaceutical companies, committed to scientific research, therapeutic innovation, and expanding global access to modern medicine.

Additional Information

The Company Eli Lilly and Compay (United States), is listed on NYSE with a market cap of $ 949.16 Billions, having an equity of $ 23.85 Billions.

With a total of 35.000 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 59.42 Billions, which generated a profit in the amount of $ 18.41 Billions.

As for its main indicators, the Company has a P/E ratio of 51.55, a P/BV ratio of 39.80 and in the last 12 months the dividend yield of LLY was at 0.55%.

The Company is traded internationally through the ticker LLY.

Market cap

$ 949.16 Billions

Equity

$ 23.85 Billions

US$ 23,850,800,000.00

Assets

$ 114.94 Billions

US$ 114,935,400,000.00

Total Shares Outstanding

897.00 Millions

897,000,000

Average Daily Trading Volume

$ 3.94 Millions

US$ 3,940,114.38

Sector

Health

Industry

Pharmaceutical Products

LLY

businesses that generate revenue for Eli Lilly

Regions where Eli Lilly generates revenue

LLY revenue and profits

Financial Results LLY

DRAG THE FRAME TO SEE MORE DATA

LLY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.90 35,21% (12M)

P/E

211.13

3.41%

ROE

0.64%

P/BV

1.35

CI - Cigna

$ 271.47 --16,47% (12M)

P/E

12.03

2.13%

ROE

14.63%

P/BV

1.76

CNC - Centene

$ 38.17 --37,86% (12M)

P/E

-3.39

0.00%

ROE

-25.12%

P/BV

0.85

HUM - Humana

$ 229.20 --23,29% (12M)

P/E

21.11

1.56%

ROE

6.95%

P/BV

1.47

SNY - Sanofi

$ 49.15 6,16% (12M)

P/E

10.79

4.46%

ROE

13.90%

P/BV

1.50

HCA - HCA Healthcare

$ 501.04 53,80% (12M)

P/E

18.03

0.57%

ROE

-293.84%

P/BV

-52.99

NVS - Novartis

$ 126.54 26,28% (12M)

P/E

17.04

3.04%

ROE

32.16%

P/BV

5.48

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 77.90 35,21% (12 M)

P/L

211.13

3.41%

ROE

0.64%

P/VP

1.35

CI - Cigna

$ 271.47 --16,47% (12 M)

P/L

12.03

2.13%

ROE

14.63%

P/VP

1.76

CNC - Centene

$ 38.17 --37,86% (12 M)

P/L

-3.39

0.00%

ROE

-25.12%

P/VP

0.85

HUM - Humana

$ 229.20 --23,29% (12 M)

P/L

21.11

1.56%

ROE

6.95%

P/VP

1.47

SNY - Sanofi

$ 49.15 6,16% (12 M)

P/L

10.79

4.46%

ROE

13.90%

P/VP

1.50

HCA - HCA Healthcare

$ 501.04 53,80% (12 M)

P/L

18.03

0.57%

ROE

-293.84%

P/VP

-52.99

NVS - Novartis

$ 126.54 26,28% (12 M)

P/L

17.04

3.04%

ROE

32.16%

P/VP

5.48

Frequently Asked Questions

What is the price of Eli Lilly (LLY) today?

The price of Eli Lilly (LLY) today is $ 1,070.16, with return of 43.04% compared to the last year. The price of Eli Lilly (LLY) started the year trading around $ 778.07 and today it is at $ 1,070.16. Follow the real-time price chart, the historical price of Eli Lilly (LLY) and international markets.

When does Eli Lilly (LLY) pay dividends?

Eli Lilly (LLY) distributed dividends in the last year,in the months of March, June and September totaling $ 4.50. The Dividend Yield for the last 12 months is 0.55%.

Is Eli Lilly (LLY) worth it?

Currently, Eli Lilly (LLY) is priced at $ 1,070.16, with a P/E of 51.55%, representando um desvio de 6,223% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 43.04 in its price and distributed $ 4.50 in dividends, resulting in a Dividend Yield of 0.55%. The total shareholder return was 43.04%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Eli Lilly (LLY) stock?

Investing in stocks of Eli Lilly (LLY) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Eli Lilly (LLY) yield today?

The yield of Eli Lilly (LLY) was 29.84% in the last month, 43.04% in the last year and 668.63% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 5.80 in dividends, a Dividend Yield of 0.55%.

If you wanted to buy 100 stocks of Eli Lilly (LLY) today, the total investment would be $ 107,016.00, based on the current price of $ 1,070.16.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 153,075.69
In 5 years: $ 822,557.08
In 10 years: $ 1,668,197.51

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

LLY

Eli Lilly and Compay

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of LLY

review the fundamentals of Eli Lilly shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.55%

5-year average DY: 1.14%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Eli Lilly

Eli Lilly and Compay

United States

124 years

1970

35.000

History and Founding of Eli Lilly and Company

Additional Information

PROFIT X PRICE LLY

Financial Results LLY

LLY cash flow

asset growth - LLY

LLY balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

NVS - Novartis

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions